Aroa Biosurgery aiming for ASX IPO

Aroa Biosurgery, manufacturer of high-tech wound dressings and soft tissue repair products, is targeting an IPO at a $300mil valuation on the Australian Stock Exchange. With a May target listing date, this comes hot on the heels of the company posting $25mil in revenue and the first year in profit, and would be huge for the New Zealand biotech industry.

Read more here: https://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=12306150 and https://www.afr.com/street-talk/aroa-biosurgery-to-patch-up-300m-listing-20200204-p53xhm

Leave a Reply